Clinical Trials Logo

Clinical Trial Summary

This study is to test the effectiveness of pregabalin in treating nerve pain caused by diabetes. The suitable subjects will be patients who also use an non-steroid anti-inflammatory drug for another pain which is not related to the diabetic nerve pain.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT01455415
Study type Interventional
Source Pfizer
Contact
Status Completed
Phase Phase 3
Start date December 2011
Completion date December 2013

See also
  Status Clinical Trial Phase
Not yet recruiting NCT06158529 - High-frequency Electrical Spinal Cord Stimulation Versus Electrical Spinal Cord Stimulation in the Treatment of Diabetic Peripheral Neuropathic Pain N/A
Completed NCT01726413 - A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). Phase 2
Completed NCT05123196 - Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy Phase 2
Terminated NCT04246619 - Efficacy of Pregabalin and Duloxetine in Patients With PDPN: the Effect of Pain on Cognitive Function, Sleep and Quality of Life Phase 4
Recruiting NCT03520608 - Painful Diabetic Peripheral Neuropathy Study of Chinese OutPatiEnt
Completed NCT03172598 - Study to Assess the Efficacy, Safety and Tolerability of MT- 8554 in Subjects With Painful Diabetic Peripheral Neuropathy Phase 2
Terminated NCT01280747 - Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study
Completed NCT03176472 - Ricolinostat in Patients With Painful Diabetic Peripheral Neuropathy Phase 2